AR107829A1 - Monotartrato de vinorelbina y su uso farmacéutico - Google Patents
Monotartrato de vinorelbina y su uso farmacéuticoInfo
- Publication number
- AR107829A1 AR107829A1 ARP170100572A ARP170100572A AR107829A1 AR 107829 A1 AR107829 A1 AR 107829A1 AR P170100572 A ARP170100572 A AR P170100572A AR P170100572 A ARP170100572 A AR P170100572A AR 107829 A1 AR107829 A1 AR 107829A1
- Authority
- AR
- Argentina
- Prior art keywords
- monotartrate
- crystalline
- vinorelbin
- vinorelbine monotartrate
- pharmaceutical use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Monotartrato de vinorelbina cristalino y su uso para la prevención y el tratamiento del cáncer, particularmente el cáncer de pulmón no microcítico o el cáncer de mama. También se refiere a un método correspondiente para la fabricación de monotartrato de vinorelbina cristalino. Reivindicación 10: El monotartrato de vinorelbina cristalino de acuerdo con la reivindicación 8 ó 9, caracterizado porque el monotartrato de vinorelbina hidrato cristalino se caracteriza por un patrón de difracción de polvo de rayos X que comprende picos a ángulos de difracción promedio (2q) de 7,9º, 9,5º, 10,3º, 10,8º, y 13,4º, 13,6º y 14,5º (cada ± 0,2º).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2016/055040 WO2017152972A1 (en) | 2016-03-09 | 2016-03-09 | Vinorelbine monotartrate and its pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
AR107829A1 true AR107829A1 (es) | 2018-06-13 |
Family
ID=55521706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170100572A AR107829A1 (es) | 2016-03-09 | 2017-03-08 | Monotartrato de vinorelbina y su uso farmacéutico |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190092792A1 (es) |
EP (1) | EP3426665A1 (es) |
JP (1) | JP2019508436A (es) |
CN (1) | CN108779129A (es) |
AR (1) | AR107829A1 (es) |
BR (1) | BR112018067637A2 (es) |
CA (1) | CA3014473A1 (es) |
RU (1) | RU2730521C2 (es) |
TW (1) | TW201734023A (es) |
UY (1) | UY37139A (es) |
WO (1) | WO2017152972A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115611927A (zh) * | 2020-01-06 | 2023-01-17 | 刘力 | 长春抗肿瘤药物的新化合物 |
CN114621258B (zh) * | 2022-04-08 | 2024-06-25 | 海南长春花药业有限公司 | 一种酒石酸长春瑞滨的纯化方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
DK1530459T3 (da) | 2002-05-31 | 2010-07-19 | Rp Scherer Technologies Llc | Oral farmaceutisk sammensætning til bløde kapsler indeholdende vinorelbin samt fremgangsmåde til behandling |
CN1437942A (zh) * | 2003-02-08 | 2003-08-27 | 杭州华卫制药技术开发有限公司 | 注射用长春瑞滨粉针剂及制备方法 |
CN1245409C (zh) * | 2003-06-03 | 2006-03-15 | 浙江海正药业股份有限公司 | 长春瑞滨合成中间体脱水长春碱的制备方法 |
CN1552716A (zh) * | 2003-06-03 | 2004-12-08 | 浙江海正药业股份有限公司 | 合成长春瑞滨的方法 |
PL1830817T3 (pl) | 2004-12-30 | 2013-06-28 | Pf Medicament | Stała trwała dyspersja pochodnej alkaloidu Vinca i sposób jej wytwarzania |
FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
CN101284842B (zh) * | 2008-05-19 | 2010-06-09 | 华中科技大学 | 用硫酸长春碱合成长春瑞滨酒石酸盐的方法 |
CN102766149B (zh) * | 2012-07-05 | 2014-09-24 | 深圳万乐药业有限公司 | 一种酒石酸长春瑞滨的制备方法 |
CN104725405A (zh) * | 2013-12-20 | 2015-06-24 | 中国医药研究开发中心有限公司 | 长春瑞滨的制备方法 |
-
2016
- 2016-03-09 CN CN201680083098.9A patent/CN108779129A/zh active Pending
- 2016-03-09 US US16/082,680 patent/US20190092792A1/en not_active Abandoned
- 2016-03-09 CA CA3014473A patent/CA3014473A1/en not_active Abandoned
- 2016-03-09 RU RU2018129465A patent/RU2730521C2/ru active
- 2016-03-09 WO PCT/EP2016/055040 patent/WO2017152972A1/en active Application Filing
- 2016-03-09 BR BR112018067637A patent/BR112018067637A2/pt not_active Application Discontinuation
- 2016-03-09 JP JP2018547417A patent/JP2019508436A/ja not_active Ceased
- 2016-03-09 EP EP16709044.8A patent/EP3426665A1/en not_active Withdrawn
-
2017
- 2017-03-01 UY UY0001037139A patent/UY37139A/es not_active Application Discontinuation
- 2017-03-08 AR ARP170100572A patent/AR107829A1/es unknown
- 2017-03-08 TW TW106107583A patent/TW201734023A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA3014473A1 (en) | 2017-09-14 |
RU2018129465A (ru) | 2020-04-09 |
RU2018129465A3 (es) | 2020-04-09 |
JP2019508436A (ja) | 2019-03-28 |
BR112018067637A2 (pt) | 2019-01-02 |
UY37139A (es) | 2017-10-31 |
TW201734023A (zh) | 2017-10-01 |
WO2017152972A1 (en) | 2017-09-14 |
EP3426665A1 (en) | 2019-01-16 |
US20190092792A1 (en) | 2019-03-28 |
RU2730521C2 (ru) | 2020-08-24 |
CN108779129A (zh) | 2018-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019003636A1 (es) | Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson. | |
BR112017009497A2 (pt) | polinucleotídeos de aadc para o tratamento da doença de parkinson | |
MX2018005019A (es) | Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas. | |
MX2017013801A (es) | Métodos para tratar el cáncer. | |
CL2016001895A1 (es) | Compuestos | |
TW201613901A (en) | New compounds | |
MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
MX2018003893A (es) | Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos. | |
PH12019501690A1 (en) | Pyrimidine compound and pharmaceutical use thereof | |
MX2015010829A (es) | Compuestos terapeuticos y sus usos. | |
MX2016009332A (es) | Conjugado de farmaco citotoxico-ligando, metodo de preparacion del mismo y uso del mismo. | |
TW201711997A (en) | 2-arylamino pyridine, pyridine or triazine derivative, preparation method and use thereof | |
MX2017015936A (es) | Nueva composicion farmaceutica que comprende agentes tensioactivos no ionicos. | |
MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
IN2014MU00303A (es) | ||
CL2018003431A1 (es) | Tratamiento de la enfermedad de parkinson. | |
MX2016016388A (es) | Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña. | |
CO2019002361A2 (es) | 1–arilnaftiridin–3–carboxamidas 7–sustituidas y su uso | |
PH12016501039A1 (en) | Pharmaceutical dosage forms | |
CO2020004984A2 (es) | Proceso para preparar el benzotiofen-2-il boronato | |
MX2017006513A (es) | Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. | |
AR107829A1 (es) | Monotartrato de vinorelbina y su uso farmacéutico | |
MX2019000677A (es) | Células miméticas de células b. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |